These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12243766)

  • 1. Interaction of d-tubocurarine analogs with mutant 5-HT(3) receptors.
    Yan D; White MM
    Neuropharmacology; 2002 Sep; 43(3):367-73. PubMed ID: 12243766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of D-tubocurarine analogs with the 5HT3 receptor.
    Yan D; Pedersen SE; White MM
    Neuropharmacology; 1998; 37(2):251-7. PubMed ID: 9680250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nondepolarizing neuromuscular blockers inhibit the serotonin-type 3A receptor expressed in Xenopus oocytes.
    Min KT; Wu CL; Yang J
    Anesth Analg; 2000 Feb; 90(2):476-81. PubMed ID: 10648343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of d-tubocurarine analogs with the Torpedo nicotinic acetylcholine receptor. Methylation and stereoisomerization affect site-selective competitive binding and binding to the noncompetitive site.
    Pedersen SE; Papineni RV
    J Biol Chem; 1995 Dec; 270(52):31141-50. PubMed ID: 8537377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of loop F residues in determining differential d-tubocurarine potencies in mouse and human 5-hydroxytryptamine 3A receptors.
    Zhang R; Wen X; Militante J; Hester B; Rhubottom HE; Sun H; Leidenheimer NJ; Yan D; White MM; Machu TK
    Biochemistry; 2007 Feb; 46(5):1194-204. PubMed ID: 17260949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiemetics of the 5-hydroxytryptamine 3A antagonist class inhibit muscle nicotinic acetylcholine receptors.
    Paul M; Callahan R; Au J; Kindler CH; Yost CS
    Anesth Analg; 2005 Sep; 101(3):715-721. PubMed ID: 16115980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle relaxants and 5-HT(3) receptors.
    Gyermek L
    Anesth Analg; 2000 Oct; 91(4):1039. PubMed ID: 11004075
    [No Abstract]   [Full Text] [Related]  

  • 8. Mapping residues in the ligand-binding domain of the 5-HT(3) receptor onto d-tubocurarine structure.
    Yan D; Meyer JK; White MM
    Mol Pharmacol; 2006 Aug; 70(2):571-8. PubMed ID: 16723497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping spatial relationships between residues in the ligand-binding domain of the 5-HT3 receptor using a molecular ruler.
    Nyce HL; Stober ST; Abrams CF; White MM
    Biophys J; 2010 May; 98(9):1847-55. PubMed ID: 20441748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of amino acids and subunits in determining the inhibition of nicotinic acetylcholine receptors by competitive antagonists.
    Dilger JP; Vidal AM; Liu M; Mettewie C; Suzuki T; Pham A; Demazumder D
    Anesthesiology; 2007 Jun; 106(6):1186-95. PubMed ID: 17525594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features of the ligand-binding domain of the serotonin 5HT3 receptor.
    Yan D; Schulte MK; Bloom KE; White MM
    J Biol Chem; 1999 Feb; 274(9):5537-41. PubMed ID: 10026168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitation by substance P and inhibition by (+)-tubocurarine of the 5-HT3 receptor-mediated Bezold-Jarisch reflex in rats.
    Malinowska B; Godlewski G; Buczko W; Göthert M
    Eur J Pharmacol; 1996 Nov; 315(2):159-64. PubMed ID: 8960879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.
    Jensen TN; Nielsen J; Frederiksen K; Ebert B
    Eur J Pharmacol; 2006 May; 538(1-3):23-31. PubMed ID: 16647053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is d-tubocurarine an antiemetic?
    Gyermek L
    Acta Anaesthesiol Sin; 1996 Mar; 34(1):53. PubMed ID: 9084521
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
    Brüss M; Molderings GJ; Bönisch H; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, expression, and characterization of ferret 5-HT(3) receptor subunit.
    Mochizuki S; Watanabe T; Miyake A; Saito M; Furuichi K
    Eur J Pharmacol; 2000 Jul; 399(2-3):97-106. PubMed ID: 10884508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The actions of muscle relaxants at nicotinic acetylcholine receptor isoforms.
    Garland CM; Foreman RC; Chad JE; Holden-Dye L; Walker RJ
    Eur J Pharmacol; 1998 Sep; 357(1):83-92. PubMed ID: 9788777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site selectivity of competitive antagonists for the mouse adult muscle nicotinic acetylcholine receptor.
    Liu M; Dilger JP
    Mol Pharmacol; 2009 Jan; 75(1):166-73. PubMed ID: 18842832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
    Sun H; McCardy EA; Machu TK; Blanton MP
    J Pharmacol Exp Ther; 1999 Jul; 290(1):129-35. PubMed ID: 10381768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of [14C]guanidinium accumulation in NG 108-15 cells exposed to serotonin 5-HT3 receptor ligands and substance P.
    Emerit MB; Riad M; Fattaccini CM; Hamon M
    J Neurochem; 1993 Jun; 60(6):2059-67. PubMed ID: 7684066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.